Regenics AS
PrivateLast Round
Private Placement
Aug 13, 2024
Est. Valuation
$9.5M
Total Funding Raised
$1.09M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Regenics AS operates in Healthcare & Life Sciences and is based in Oslo. Its latest recorded funding round was a Private Placement round in August 2024.
Regenics AS is a biotechnology company that develops therapeutics for tissue regeneration, including a recombinant human protein to stimulate the regeneration of skin and bone.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Sustainable Materials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Regenics AS Comparables
Compare Regenics AS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Omeza | 80% | |
| Miha Biotech Inc. | 77% | |
| Imbed Biosciences | 77% |
For institutional investors. Book with your work email.
Regenics AS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Aug 13, 2024 | ||||
| Grant | Mar 23, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Regenics AS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund Denmark | Grant |
| Swedish Research Council for Sustainable Development (Formas) | Grant |
| The Research Council of Norway | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 17, 2026
Grew 38% QoQ from 8 to 11 employees.
- Jul 26, 2026
Monthly visitors increased 87% MoM.
For institutional investors. Book with your work email.
Regenics AS Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Regenics AS's valuation, stock price, and market status.
Is Regenics AS a public or private company?
Regenics AS is a private company.
What is the current stock price of Regenics AS?
Regenics AS is a private company, so its shares have no public market price. Caplight tracks Regenics AS's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Regenics AS worth (valuation)?
Regenics AS's valuation is estimated at $9.5M based on funding round data.
Can I buy Regenics AS stock?
Regenics AS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Regenics AS's last funding round?
Regenics AS's most recent funding round was Private Placement on August 13, 2024.
Who are the main investors in Regenics AS?
Key investors in Regenics AS include Innovation Fund Denmark, Swedish Research Council for Sustainable Development (Formas), The Research Council of Norway.
Will Regenics AS IPO soon?
No public IPO plans have been announced for Regenics AS.
How can I track Regenics AS secondary market activity?
Caplight tracks bids, offers, and trades in Regenics AS's shares on secondary markets.